NCT02393248 2023-01-06Open-Label, Dose-Escalation Study of Pemigatinib in Subjects With Advanced Malignancies - (FIGHT-101)Incyte CorporationPhase 1/2 Terminated201 enrolled 71 charts
NCT00003406 2013-03-26Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Refractory CancerNational Cancer Institute (NCI)Phase 1/2 Completed30 enrolled